SNDX
Syndax Pharmaceuticals Inc
Halal Rating :
Last Price
$13.08
Last updated:
Market Cap
-
7D Change
2.19%
1 Year Change
-37.27%
Company Overview
Industries
Exchange
Next Earnings Date
Syndax Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing innovative cancer therapies. The company focuses on developing novel therapies for cancer treatment, with a pipeline of products in various stages of clinical development. Their main focus is on developing medicines that disrupt cancer cell resistance mechanisms.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| Sept. 30, 2024 | $12.5m | $102.1m | - | $23000.0 | 0.00% | 0.02% |
| June 30, 2024 | $3.5m | $77.76m | - | $45000.0 | 0.00% | 0.06% |
Company Impact
Help us evaluate Syndax Pharmaceuticals Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.